Challenges in Targeting a Basic Helix-Loop-Helix Transcription Factor with Hydrocarbon-Stapled Peptides

Area of Science:

• Molecular Biology
• Cancer Research
• Drug Discovery

Background:

• Basic helix-loop-helix (bHLH) transcription factors regulate critical cellular processes like proliferation and differentiation.
• Dysregulation of bHLH factors is implicated in various diseases, including glioblastoma multiforme.
• Alpha-helical decoys are explored as a therapeutic strategy to inhibit pathogenic bHLH activity.

Purpose of the Study:

• To develop and assess stabilized alpha-helices of OLIG2 (SAH-OLIG2) as peptide decoys.
• To investigate the disruption of OLIG2 homodimerization, a driver of glioblastoma development and chemoresistance.
• To identify potential limitations in targeting bHLH transcription factors with peptide-based therapeutics.

Main Methods:

• Construction of a library of hydrocarbon-stapled peptides mimicking OLIG2 alpha-helices.
• Evaluation of the structural stability of stapled bHLH constructs.
• Assessment of the peptides' ability to dissociate OLIG2 dimers from DNA.
• Analysis of OLIG2 self-association and stability, including C-terminal domain contributions.

Main Results:

• Hydrocarbon stapling successfully stabilized the alpha-helical structure of bHLH constructs.
• Sequence-specific dissociation of OLIG2 dimers from DNA was not achieved.
• An unanticipated role for the C-terminal domain in OLIG2 self-association and stability was uncovered.

Conclusions:

• Peptide-based targeting of OLIG2 homodimerization for glioblastoma therapy faces challenges.
• The multifactorial binding determinants and positively charged amino acid sequences of bHLH factors present liabilities for peptide decoys.
• Further research is needed to overcome these hurdles for effective bHLH-targeted therapies.